Seeing Is Believing
with an average price target of $1.78. This is a potential upside of $1.78 (0%) from yesterday's end of day stock price of $0.
Antares Pharma's activity chart (see below) currently has 38 price targets and 25 ratings on display.
Analysts average stock forecasts to be materialized ratio is 37.5% with an average time for these price targets to be met of 265 days.
Most recent stock forecast was given by ELLIOT WILBUR from RAYMOND JAMES on 13-Apr-2022. First documented stock forecast 07-Oct-2013.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$6
$0.41 (7.33%)
$6
3 years 6 months 11 days ago
(13-Apr-2022)
0/3 (0%)
$0.44 (7.91%)
Hold
$5.6
$0.01 (0.18%)
$6
3 years 6 months 11 days ago
(13-Apr-2022)
2/4 (50%)
$0.04 (0.72%)
374
Hold
3 years 6 months 11 days ago
(13-Apr-2022)
7/8 (87.5%)
$1.2 (31.58%)
367
Hold
$7
3 years 6 months 12 days ago
(12-Apr-2022)
0/1 (0%)
$2.85 (68.67%)
Buy
$8
$2.41 (43.11%)
$7
6 years 11 months 19 days ago
(05-Nov-2018)
2/4 (50%)
$4.39 (121.61%)
584
What is ATRS (Antares Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on ATRS (Antares Pharma) with a proven track record?
Which analyst has the current lower performing score on ATRS (Antares Pharma) with a proven track record?
Which analyst has the most public recommendations on ATRS (Antares Pharma)?
Which analyst is the currently most bullish on ATRS (Antares Pharma)?
Which analyst is the currently most reserved on ATRS (Antares Pharma)?